{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:58:48Z","timestamp":1793249928605,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T00:00:00Z","timestamp":1699747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.conctc.2023.101232","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T07:48:26Z","timestamp":1700639306000},"page":"101232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A phase II\/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9\u201312 month old healthy infants"],"prefix":"10.1016","volume":"36","author":[{"given":"Subhash","family":"Thuluva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SubbaReddy","family":"Gunneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4197-9457","authenticated-orcid":false,"given":"Kishore","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rammohan Reddy","family":"Mogulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Yerroju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyankumar","family":"Peta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pothakamuri Venkata","family":"Suneetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh V.","family":"Matur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10111","key":"10.1016\/j.conctc.2023.101232_bib1","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"issue":"9984","key":"10.1016\/j.conctc.2023.101232_bib2","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","article-title":"Rubella","volume":"385","author":"Lambert","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.conctc.2023.101232_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41591-021-01237-5","article-title":"A dangerous measles future looms beyond the COVID-19 pandemic","volume":"27","author":"Durrheim","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.conctc.2023.101232_bib4","volume":"2016","year":"2017"},{"issue":"10332","key":"10.1016\/j.conctc.2023.101232_bib5","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(21)02691-X","article-title":"Rubella","volume":"399","author":"Winter","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.conctc.2023.101232_bib6","doi-asserted-by":"crossref","first-page":"e1399","DOI":"10.1016\/S2214-109X(20)30320-X","article-title":"The epidemiology of rubella, 2007-18: an ecological analysis of surveillance data","volume":"8","author":"Patel","year":"2020","journal-title":"Lancet Global Health"},{"issue":"9","key":"10.1016\/j.conctc.2023.101232_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s13312-019-1636-x","article-title":"Measles and rubella surveillance","volume":"56","author":"Shastri","year":"2019","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.conctc.2023.101232_bib8","series-title":"Measles and Rubella Elimination","author":"Organization","year":"2023"},{"key":"10.1016\/j.conctc.2023.101232_bib9","unstructured":"W.H. Organization, Measles and rubella strategic framework 2021\u20132030. 2020. Measles and rubella strategic framework: 2021-2030 (who.int)."},{"issue":"7","key":"10.1016\/j.conctc.2023.101232_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01430-6","article-title":"Emergence of measles during the COVID-19 pandemic threatens Pakistan\u2019s children and the wider region","volume":"27","author":"Rana","year":"2021","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.conctc.2023.101232_bib11","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.4103\/jfmpc.jfmpc_319_19","article-title":"Coverage survey of Measles-Rubella mass vaccination campaign in a rural area in Tamil Nadu","volume":"8","author":"Priyadharshini","year":"2019","journal-title":"J. Fam. Med. Prim. Care"},{"issue":"4","key":"10.1016\/j.conctc.2023.101232_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/ijmr.IJMR_4113_20","article-title":"Immunogenicity of measles-rubella vaccine administered under India\u2019s Universal Immunization Programme in the context of measles-rubella elimination goal: a longitudinal study","volume":"157","author":"Verma","year":"2023","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.conctc.2023.101232_bib13","first-page":"155","article-title":"Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age","volume":"100","author":"Singh","year":"1994","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.conctc.2023.101232_bib14","first-page":"183","article-title":"Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age","volume":"118","author":"Yadav","year":"2003","journal-title":"Indian J. Med. Res."},{"issue":"24","key":"10.1016\/j.conctc.2023.101232_bib15","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1016\/j.vaccine.2020.04.013","article-title":"Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: a longitudinal study","volume":"38","author":"Wanlapakorn","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.conctc.2023.101232_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1473-3099(18)30650-9","article-title":"Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial","volume":"19","author":"Li","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"27","key":"10.1016\/j.conctc.2023.101232_bib17","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/S0264-410X(00)00096-7","article-title":"Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age","volume":"18","author":"Klinge","year":"2000","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.conctc.2023.101232_bib18","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2014.04.044","article-title":"Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children","volume":"32","author":"He","year":"2014","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.conctc.2023.101232_bib19","first-page":"S116","article-title":"Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age","volume":"189","author":"Redd","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"47","key":"10.1016\/j.conctc.2023.101232_bib20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.15585\/mmwr.mm7147a1","article-title":"Progress toward regional measles elimination - worldwide, 2000-2021","volume":"71","author":"Minta","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"5","key":"10.1016\/j.conctc.2023.101232_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13312-018-1282-8","article-title":"Long-term seroprotection rates following second dose of measles as MMR vaccine at 15 months in Indian children","volume":"55","author":"Hansashree","year":"2018","journal-title":"Indian Pediatr."},{"issue":"3","key":"10.1016\/j.conctc.2023.101232_bib22","first-page":"302","article-title":"Immune response to second dose of MMR vaccine in Indian children","volume":"134","author":"Gomber","year":"2011","journal-title":"Indian J. Med. Res."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423001783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423001783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:08:34Z","timestamp":1762520914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865423001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":22,"alternative-id":["S2451865423001783"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101232","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase II\/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9\u201312 month old healthy infants","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101232"}}